• Dr. Douglas Anderson grew up in Franklin, Tennessee, just south of Nashville. He attended Vanderbilt University, where he received his bachelor’s and master’s degrees in biomedical engineering. After graduation, he remained at Vanderbilt to attend medical school before relocating to Atlanta in 2009. Once in Atlanta, he completed his residency in general surgery and fellowship in transplant surgery at Emory University. While there, he spent two years in the Emory Transplant Center laboratory researching co-stimulation blockade-based immunosuppression strategies in a pre-clinical model of kidney transplantation.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2022 Perpetuating Disparity: Failure of the Kidney Transplant System to Provide the Most Kidney Transplants to Communities With the Greatest NeedAnnals of Surgery.  276:597-604. 2022
    2022 Greater community vulnerability is associated with poor living donor navigator program fidelitySurgery.  172:997-1004. 2022
    2022 Abnormal time-zero histology is predictive of kidney transplant outcomesClinical Transplantation.  36. 2022
    2022 Donor-reported barriers to living kidney donor follow-upClinical Transplantation.  36. 2022
    2022 First clinical-grade porcine kidney xenotransplant using a human decedent modelAmerican Journal of Transplantation.  22:1037-1053. 2022
    2022 T and B lymphocyte dynamics after genetically-modified pig-to-baboon kidney xenotransplantation with an anti-CD40mAb-based immunosuppressive regimenTransplant Immunology.  71. 2022
    2022 Progress towards solving the donor organ shortageNature Reviews Nephrology2022
    2021 Histopathology of pig kidney grafts with/without expression of the carbohydrate Neu5Gc in immunosuppressed baboonsXenotransplantation.  28. 2021
    2021 Evidence suggesting that deletion of expression of N-glycolylneuraminic acid (Neu5Gc) in the organ-source pig is associated with increased antibody-mediated rejection of kidney transplants in baboonsXenotransplantation.  28. 2021
    2021 Self-advocacy is associated with lower likelihood of living donor kidney transplantation 2021
    2021 Early Outcomes With the Liver-kidney Safety NetTransplantation.  105:1261-1272. 2021
    2021 What Therapeutic Regimen Will Be Optimal for Initial Clinical Trials of Pig Organ Transplantation?Transplantation.  105:1143-1155. 2021
    2021 Pig kidney xenotransplantation: Progress toward clinical trialsClinical Transplantation.  35. 2021
    2021 Suggested Patient Selection Criteria for Initial Clinical Trials of Pig Kidney Xenotransplantation in the United StatesTransplantation.  1904-1908. 2021
    2020 Old World Monkeys are less than ideal transplantation models for testing pig organs lacking three carbohydrate antigens (Triple-Knockout)Scientific Reports.  10. 2020
    2020 The final obstacle to successful pre-clinical xenotransplantation?Xenotransplantation.  27. 2020
    2020 Combined Thoracic-Kidney Transplantation Practices May Exacerbate Existing Geographic Disparities in Access to Deceased Donor Kidney TransplantationJournal of Heart and Lung Transplantation.  39:S366-S367. 2020
    2020 Clinical pig kidney xenotransplantation: How close are we?Journal of the American Society of Nephrology.  31:12-21. 2020
    2020 De Novo Belatacept in a Kidney-After-Heart Transplant RecipientTransplantation Direct2020
    2020 Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?Transplantation.  1215-1228. 2020
    2019 Mitigating Racial and Sex Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation's Longest Single-center Kidney ChainAnnals of Surgery.  270:639-646. 2019
    2019 Corticosteroids and methotrexate as adjuvants to costimulation blockade in non-human primate renal transplantationClinical Transplantation.  33. 2019
    2018 Transplantation versus resection for hilar cholangiocarcinoma: An argument for shifting treatment paradigms for resectable diseaseAnnals of Surgery.  267:797-805. 2018
    2017 Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation ModelAmerican Journal of Transplantation.  17:1193-1203. 2017
    2016 Anti-Leukocyte Function-Associated Antigen 1 Therapy in a Nonhuman Primate Renal Transplant Model of Costimulation Blockade-Resistant RejectionAmerican Journal of Transplantation.  16:1456-1464. 2016
    2015 A pilot trial targeting the icos-icos-l pathway in nonhuman primate kidney transplantationAmerican Journal of Transplantation.  15:984-992. 2015
    2013 Inhibition of αvβ6 promotes acute renal allograft rejection in nonhuman primatesAmerican Journal of Transplantation.  13:3085-3093. 2013
    2013 Primate Models in organ transplantationCold Spring Harbor Perspectives in Medicine.  3. 2013
    2013 Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletionAmerican Journal of Transplantation.  13:320-328. 2013
    2009 Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal gangliaJournal of Neurochemistry.  110:378-389. 2009
    2008 Simulation study of susceptibility gradients leading to focal myocardial signal lossJournal of Magnetic Resonance Imaging.  28:1402-1408. 2008
    2003 Organotypic raft cultures as an effective in vitro tool for understanding Raman spectral analysis of tissue.Photochemistry and Photobiology.  78:517-524. 2003

    Research Overview

  • Keywords - kidney transplantation, immunosuppression
  • Investigator On

  • A Trial of Transplanting Hepatitis C-Viremic Kidneys Into Hepatitis C-Negative Kidney Recipients (THINKER-NEXT) Cost-Reimbursement  awarded by University of Pennsylvania
  • A Trial of Transplanting Hepatitis C-viremic Kidneys into Hepatitis C-Negative Kidney Recipients (THINKER-NEXT) Fixed Rate  awarded by University of Pennsylvania
  • APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • APOL1 Long-term kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients  awarded by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients - Equipment  awarded by Mount Sinai School of Medicine ^
  • HOPE in Action: A Clinical Trial of HIV-to-HIV Deceased Donor Kidney Transplantation  awarded by Johns Hopkins University
  • Impact of CCR5 Blockade in HIV + Kidney Transplant Recipients  awarded by University of California, San Francisco
  • Impact of CCR5 Blockade in HIV+Kidney Transplant Recipients  awarded by University of California, San Francisco
  • Kidney Transplantation in Recipients and Donors with HIV: Long Term Follow up Study  awarded by Johns Hopkins University
  • Private Grant  awarded by LUNG BIOTECHNOLOGY PBC
  • Private Grant  awarded by LUNG BIOTECHNOLOGY PBC
  • Private Grant  awarded by HANSA BIOPHARMA
  • Education And Training

  • Doctor of Medicine, Vanderbilt University 2009
  • Full Name

  • Douglas Anderson